FDA approves Verzenio as the first and only CDK4/6 inhibitor for certain people with HR+HER2- high-risk early breast cancer Read more
One-shot Sputnik Light vaccine demonstrates 70 per cent efficacy against Delta variant: Gamaleya Center Read more
Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster dose in those vaccinated with Covishield or Covaxin Read more
ZD7442 reduces risk of developing severe COVID-19 or death in Tackle phase-III outpatient treatment trial Read more